Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on April 8, 2025
AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
GlobeNewswire
·
April 8, 2025
BERWYN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA (WODC), …
CORRECTION: Mitolyn
GlobeNewswire
·
April 8, 2025
In a release issued under the same headline on March 31, 2025 by Mitolyn, please note that the headline has been edited from "Mitolyn Reviews (CRITICAL DOCTOR BREAKDOWN): Experts Reveal the Cellular Science Behind the Mitolyn Hype" to "Mitolyn 2025 …
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
GlobeNewswire
·
April 8, 2025
LONDON and PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has …
Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome
GlobeNewswire
·
April 8, 2025
San Jose, CA, USA, April 08, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded the Seal of Acceptance by the National Eczema Association (NEA). The …
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s Board of Directors approved …
Privia Health to Report First Quarter 2025 Results on Thursday, May 8
GlobeNewswire
·
April 8, 2025
ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press …
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced the appointment of Abid Ansari as Chief Financial Officer …
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide in Support of the Muscular Dystrophy Association throughout the Organization’s 75th Anniversary
GlobeNewswire
·
April 8, 2025
New York, April 08, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and the International Association of Fire Fighters (IAFF) are celebrating over 70 years of partnership by launching more than 1,500 ‘Fill the Boot’ fundraisers nationwide …
AMPS Raises the Bar on RBP with PriceDynamix: Delivering Elevated Member Advocacy, Smarter Savings, and Greater Accountability
GlobeNewswire
·
April 8, 2025
PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- The healthcare industry has outgrown the outdated and rigid model of Reference-Based Pricing. AMPS, a leader in healthcare cost savings and advocacy, is raising the bar with PriceDynamix, a smarter, more …
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today …
CORRECTION: ProDentim
GlobeNewswire
·
April 8, 2025
In a release issued under the same headline on April 1, 2025 by ProDentim, please note that the headline has been edited from "ProDentim Reviews (DOCTOR WARNING): Dentists …
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
GlobeNewswire
·
April 8, 2025
- 8.9 Months Median Overall Survival (mOS) in Patients with AML-Myelodysplasia-Related Changes (AML-MRC) and 8.8 mOS in All Relapsed or Refractory to Venetoclax-Based Regimens Patients; Surpassing Historical Benchmark of 2.5 Months - - Overall Response …
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
GlobeNewswire
·
April 8, 2025
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the …
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
GlobeNewswire
·
April 8, 2025
WASHINGTON, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the signing …
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics
GlobeNewswire
·
April 8, 2025
HOUSTON, April 08, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”) , a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
Hydreight Technologies Partners with Renowned Endocrinologist Dr. Franklin Joseph to Bring Globally Successful Weight Loss Brand to the U.S. via VSDHOne Platform
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., is thrilled to …
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
GlobeNewswire
·
April 8, 2025
SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 revenue increased between 57% and 61% compared to …
3D Bioprinting Market Worth US$2.4 billion | MarketsandMarkets™.
GlobeNewswire
·
April 8, 2025
Delray Beach, FL, April 08, 2025 (GLOBE NEWSWIRE) -- 3D Bioprinting Market, valued at US$1.2 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$1.3 billion in 2024 and an impressive US$2.4 billion by 2029 according to a published …
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
GlobeNewswire
·
April 8, 2025
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development …
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
GlobeNewswire
·
April 8, 2025
Company on track to commence U.S. clinical studies in 2025 to support a De Novo application for FDA approval THE WOODLANDS, TX, April 08, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device …